Dr. Holm is the director of the Phenotyping Core of the Program in Genomics, and oversees the interactions between the Gene Discover Core (GDC) participants.
Ingrid Holm's research focuses on the genetics of bone disorders. She has performed research in the role of mutations in the PHEX gene in hypophosphatemic rickets. Her studies have sought to elucidate the genetic and environmental components of disorders of bone mineralization. She is particularly interested in the contribution of environmental factors to the low bone mass seen in individuals with neuromuscular diseases, such as muscular dystrophy.
Dr. Holm is interested in the genetics of complex traits. As director of the Phenotype Core of the Program in Genomics, she has worked with researchers to develop clinical genetic research projects in diabetes, autism, congenital heart disease, and atopic dermatitis, and has her own project in the genetic contributions to congenitial hip dysplasia.
About Dr. Holm
Ingrid Holm received her MD degree from the University of California, Los Angeles. She completed an internship, residency, and post-graduate fellowships in genetics and pediatric endocrinology at Boston Children's Hospital. She received an MPH degree from Harvard School of Public Health.
Dr. Holm is Past President of Advances in Mineral Metabolism, an organization of professionals in the field of mineral metabolism.